- Staat
- PR
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 14.04.2023
- Impfdatum
- 14.04.2023
- Beginn
- 14.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Dizziness
Pallor
Syncope
Symptomtext
Presented dizzy & fainted, pale.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Allergies
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- CEPHAROSPORIN
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 10,0
- Geschlecht
- F
- Eingang
- 12.04.2023
- Impfdatum
- 12.04.2023
- Beginn
- 01.04.2023
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Syncope
Symptomtext
Pt fainted shortly after injection.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- Blood pressure and heart rate
- Aktuelle Erkrankungen
- none known of
- Vorgeschichte
- no
- Andere Medikamente
- no
- Allergien
- nkda
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 21.03.2023
- Impfdatum
- 21.03.2023
- Beginn
- 21.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Syncope
Symptomtext
Patient was feeling dizzy fainted approximately 2 minutes post-vaccination. Was alert and oriented shortly after being assisted to the ground.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Denies any major illnesses at this time
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Denies any major allergies
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 24.10.2023
- Impfdatum
- 23.10.2023
- Beginn
- 23.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asthenopia
Dizziness
Symptomtext
about about 10 min after receiving two vaccines patient felt light-headed, eyes heavy. she returned to IMZ area and like she would faint. we provided aid to help her recover and after about 15-20 min she felt fine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 31.08.2023
- Impfdatum
- 28.08.2023
- Beginn
- 29.08.2023
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Oropharyngeal pain
Urticaria
Symptomtext
States he woke up with hives on his chest and back the next morning after receiving the vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- Unkown
- Aktuelle Erkrankungen
- Was not sick date of vaccination, but had a sore throat this morning and HCP informed father that this could have been starting on date of vaccination and contributed to the hives.
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 11.07.2023
- Impfdatum
- 05.07.2023
- Beginn
- 05.07.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Symptomtext
After receiving 2 vaccines in the office, the patient walked outside with her father. As they approached their parked vehicle, the patient's father stated the patient stated she felt dizzy and her eyes closed for a few seconds. The patient's father assisted her to lie down on the parking lot. The patient's father stated that the patient did not hit her head or any other body parts. The patient was helped into a wheelchair by office staff and brought back into the office where the patient was assisted to lie down on an exam table with her feet elevated as per Dr.'s instruction. Within a few minutes the patient drank apple juice and ate crackers and stated she felt better. The patient walked out of
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- Bactrim - hives
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 11.05.2023
- Impfdatum
- 08.05.2023
- Beginn
- 11.05.2023
- Tage bis Beginn
- 3,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site swelling
Injection site warmth
Vaccination site reaction
Symptomtext
Vaccine reaction on site of injection. Left Deltoid, swollen, red, hot to the touch.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Asthma h/o anxiety
- Andere Medikamente
- Ventolin used as needed
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 08.05.2023
- Impfdatum
- 28.03.2023
- Beginn
- 10.04.2023
- Tage bis Beginn
- 13,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site nodule
Injection site warmth
Symptomtext
Patient received MenQuadfii vaccine RD and HPV vaccine LD 03/28/2023. Patient mother called 04/13 and stated child noticed a knot at the place of injection site on LD. patient did not notice the knot until about 3 days ago (4/10/23). mother states it is also warm to touch. patient denies any other problems a this time. patient instructed she can follow up with pcp if she experiences any other problems.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site nodule
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 27.04.2023
- Impfdatum
- 26.04.2023
- Beginn
- 27.04.2023
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Headache
Tinnitus
Vision blurred
Symptomtext
PATIENT SEEN 4/26/2023 AND MOTHER STATES PATIENT RECEIVED HER 16 YEAR OLD IMMUNIZATIONS BUT STATES PATIENT COMPLAINED OF HEADACHES WHEN SHE ARRIVED AT HER HOUSE. PATIENT WOKE UP TODAY STILL WITH HEADCAHES, RINGING TO HER EARS, AND BLURRY VISION FOR 2-3 MINS. ONLY.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- ABDOMINAL PAIN
- Vorgeschichte
- SCOLIOSIS
- Andere Medikamente
- NO
- Allergien
- NO
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 10.04.2023
- Impfdatum
- 06.04.2023
- Beginn
- 06.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pain in extremity
Vomiting
Symptomtext
Vaccine was provided during school located vaccine event. School nurse notified clinic that the student had vomited one time by 1 P.M. Advised nurse to notify student's parent of incident and parent to follow up with PCP if needed. Vaccine information statement was provided to student at time of vaccination. 4-10-23- I called mom, to follow up with child. Mom reported he complained about arm being sore and he did vomit again on 4/7/23. Mom denies any other complaints or concerns.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- unknown
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 10.03.2023
- Impfdatum
- 06.02.2023
- Beginn
- 07.02.2023
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Myalgia
Pyrexia
Symptomtext
Patient received adult dose of vaccine and experienced fever and myalgia on day one post vaccine. Patient's parent reported patient had good relief with Tylenol and no symptoms on day two post vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myalgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Partial pacreatectomy
- Andere Medikamente
- -
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 17.02.2023
- Impfdatum
- 10.02.2023
- Beginn
- 11.02.2023
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cellulitis
Immediate post-injection reaction
Injection site erythema
Injection site pain
Injection site swelling
Injection site warmth
Pain in extremity
Symptomtext
Patient complained of pain at the injection site immediately after vaccine. Arm was "super sore over the weekend. Starting on 2/9/23, patient was describing pain as sharp and felt like something sharp was moving around in her arm. Left deltoid area became red, painful, and slightly swollen. Area was warm to touch on day of exam, redness spreading. Treated for cellulitis.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 14.02.2023
- Impfdatum
- 07.02.2023
- Beginn
- 10.02.2023
- Tage bis Beginn
- 3,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site induration
Injection site pain
Injection site swelling
Injection site warmth
Symptomtext
Below, copied from Providers clinical note on 2/10/2023. "Warm, elevated, mildly tender, erythematous local region, with well defined borders of induration"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None documented in chart.
- Vorgeschichte
- Anxiety
- Andere Medikamente
- None documented.
- Allergien
- None documented in chart.
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 13.02.2023
- Impfdatum
- 13.02.2023
- Beginn
- 13.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Nausea
Vomiting
Symptomtext
Pt complained of dizziness, nausea and vomitted x1, 10 mins after vaccination. Clear content. Patient is oriented x 4. V/S is in normal range, no SOB, legs elevated. Advised parent to extend observation for 30 mins. Pt feeling better at 5:16 pm. Pt states ? I feel regular? and symptoms fully resolved. Pt educated to go to urgent care if symptoms persist. Pt left in stable condition, accompanied by Mother and siblings.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/a
- Vorgeschichte
- N/a
- Andere Medikamente
- N/a
- Allergien
- N/a
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 03.07.2023
- Impfdatum
- 03.07.2023
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
HPV (Gardasil) due today 07/03/2023, Bexsero and MenQuadfi given to patient instead. Pt. did not receive HPV
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- -
- Geschlecht
- U
- Eingang
- 18.04.2023
- Impfdatum
- 17.03.2023
- Beginn
- 17.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
patients that were given MENQUADFI after they found out that the vaccine is not suitable for use with no reported adverse event; The excursion happened last 17 March 2023 and was reported 24 March 2023 with no reported adverse event; Initial information was received on 11-Apr-2023 regarding an unsolicited valid non-serious case received from a nurse. This case involves an 12 patients of unknown age and gender patient who stated the excursion happened last 17 march 2023 and was reported 24 march 2023 and patients that were given menquadfi after they found out that the vaccine is not suitable for use with no reported adverse event after receiving meningococcal A-C-Y-W135 (T CONJ) vaccine [Menquadfi]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 17-Mar-2023, the patient received dose of suspect meningococcal A-C-Y-W135 (T CONJ) vaccine Solution for injection (lot U7459AE, expiration date: 03-Nov-2024) (strength, frequency was unknown) via unknown route in unknown administration site for Immunisation. On 17-Mar-2023 the patient developed a non-serious event of the excursion happened last 17 march 2023 and was reported 24 march 2023 with no reported adverse event (product storage error) same day following the administration of meningococcal A-C-Y-W135 (T CONJ) vaccine. On an unknown date (in between 17-Mar-2023 to 24-Mar-2023), patients were given menquadfi after they found out that the vaccine is not suitable for use with no reported adverse event (poor quality product administered) (unknown latency) following the administration of meningococcal A-C-Y-W135 (T CONJ) vaccine. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the events. At time of reporting, the outcome was Unknown for the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 24.03.2023
- Impfdatum
- 14.02.2023
- Beginn
- 14.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Vaccine administration error DTaP was administered instead of Tdap (Boostrix). No adverse events reported
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 0,2
- Geschlecht
- M
- Eingang
- 23.03.2023
- Impfdatum
- 21.03.2023
- Beginn
- 21.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Wrong product administered
Symptomtext
Menveo vaccine given instead of Prevnar (which was due) The vaccine coordinator (which is I) noticed this mistake while entering vaccines into system, taking them out of inventory. Our clinic has a interface from our EMR to system that automatically sends the vaccines when they are entered into our EMR system. The vaccine coordinator brought this to nurses attention, then discussed with provider, clinic manager, notified vaccine rep., contacted communicable disease who verified child would be ok. Nurse contacted mother. Mother reports no signs, symptoms of reaction due to injection. She will continue to monitor patient and will report any change. Advised mother to bring child in for Prevnar immunization in 2-4 weeks.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 22.03.2023
- Impfdatum
- 24.02.2023
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
No adverse event
Symptomtext
No adverse reaction report. Dr spoke with patient and explained theoretical side effects of administering live vaccines during pregnancy. Patient follow up with O.B. on 3/13/23, 3/10/23. Next appt 4/6/23.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 21.03.2023
- Impfdatum
- 21.03.2023
- Beginn
- 21.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Symptomtext
5-11 bivalent covid ordered/12 and up bivalent covid given
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- burning with urniation
- Vorgeschichte
- ADHD
- Andere Medikamente
- Daytrana patch 20mg
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 19,0
- Geschlecht
- M
- Eingang
- 02.03.2023
- Impfdatum
- 27.02.2023
- Beginn
- 27.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
nurse a administered MENQUADFI to a pt that was supposed to get Bexerio,with no reported adverse event; Initial information received on 27-Feb-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 19 years old male patient to whom nurse administered meningococcal A-C-Y-W135 (T CONJ) vaccine [Menquadfi] who was supposed to get bexerio, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 27-Feb-2023, the patient received 0.5 mL dose of suspect meningococcal A-C-Y-W135 (T CONJ) vaccine, solution for injection (Strength: standard) (lot: U7459AE; expiry date: 03-Nov-2024) via intramuscular route in the right deltoid for immunization who was supposed to get bexerio,with no reported adverse event (wrong product administered) (same day latency). Action taken with meningococcal vaccine (Menquadfi) was not applicable. At time of reporting, the outcome was Unknown for the event nurse a administered menquadfi to a pt that was supposed to get bexerio,with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 19.01.2023
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Herpes zoster
Symptomtext
an episode of shingles; Initial information was received on 24-Jan-2023 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case is linked to cases 2023SA031061 and 2023SA029739 (CLUSTER). This case involves a 61 years old female patient who experienced an episode of shingles while receiving vaccine MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI]. The patient's past medical treatment included ACYCLOVIR with takes acyclovir daily prophylactically. The patient's past vaccination(s) included MMR in NOV-2022 and MENACTRA with on a 5 year cycle. The patient's past medical history and family history were not provided. At the time of the event, the patient had ongoing Asplenia with since JUN2012 and Diabetes mellitus with has had DM for two years. Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 20V (CRM197) (PREVNAR 20) for Immunisation. On 19-Jan-2023, the patient received total, 0.5 ml of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE (lot U7459AE and expiry 03-Nov-24) ) (formulation and strength: unknown) via intramuscular route in unknown administration site for immunization. On an unknown date the patient developed a non-serious an episode of shingles (herpes zoster) (unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE. Action taken with MENINGOCOCCAL VACCINE (MENQUADFI) was not applicable. It was not reported if the patient received a corrective treatment for the event (an episode of shingles). At time of reporting, the outcome was Unknown for the event an episode of shingles.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Herpes zoster
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Asplenia (since JUN2012); Diabetes mellitus (has had DM for two years)
- Vorgeschichte
- -
- Andere Medikamente
- PREVNAR 20
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 09.01.2023
- Impfdatum
- 09.01.2023
- Beginn
- 09.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Patient was given bivalent 12 + years instead of bivalent 5-11 years. No side effects noted at time of dose given.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -